Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

Abstract

Unmitigated spread in Brazil Despite an extensive network of primary care availability, Brazil has suffered profoundly during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Using daily data from state health offices, Castro et al. analyzed the pattern of spread of COVID-19 cases and deaths in the country from February to October 2020. Clusters of deaths before cases became apparent indicated unmitigated spread. SARS-CoV-2 circulated undetected in Brazil for more than a month as it spread north from Sã o Paulo. In Manaus, transmission reached unprecedented levels after a momentary respite in mid-2020. Faria et al. tracked the evolution of a new, more aggressive lineage called P.1, which has 17 mutations, including three (K417T, E484K, and N501Y) in the spike protein. After a period of accelerated evolution, this variant emerged in Brazil during November 2020. Coupled with the emergence of P.1, disease spread was accelerated by stark local inequalities and political upheaval, which compromised a prompt federal response. Science , abh1558 and abh2644, this issue p. 821 and p. 815

Cited by papers we hold 29

• Temporal dynamics of SARS-CoV-2 phylogenetic diversity in Central Brazil reveals evolutionary shifts among variants of concern during the pandemic · 2025
  Not checked
• SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study · 2022
  Not checked
• SARS-CoV-2 Variant Determination Through SNP Assays in Samples From Industry Workers From Rio de Janeiro, Brazil · 2022
  Not checked
• Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021 · 2022
  Not checked
• Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences · 2022
  No notice
• SARS-CoV-2 variants of concern surveillance including Omicron using RT-PCR–based genotyping offers comparable performance to whole genome sequencing · 2022
  Not checked
• Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa · 2022
  No notice
• Global disparities in SARS-CoV-2 genomic surveillance · 2022
  No notice
• The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance · 2022
  No notice
• Predicting the mutational drivers of future SARS-CoV-2 variants of concern · 2022
  No notice
• Early detection and surveillance of SARS-CoV-2 genomic variants in wastewater using COJAC · 2022
  No notice
• SARS-CoV-2 Variants, Vaccines, and Host Immunity · 2022
  No notice
• Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant · 2022
  No notice
• The effect of COVID-19 vaccination in Italy and perspectives for living with the virus · 2021
  Not checked
• Modeling the onset of symptoms of COVID-19: Effects of SARS-CoV-2 variant. · 2021
  Not checked
• COVID-19 Mechanisms in the Human Body—What We Know So Far · 2021
  Not checked
• Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants · 2021
  No notice
• Global variation in sequencing impedes SARS-CoV-2 surveillance. · 2021
  Not checked
• Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant · 2021
  No notice
• COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies · 2021
  No notice

and 9 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.